Clinical Trials Browser

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

Clinical Trials

MEND-IT II

I-SPY

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

REGOSTA

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

T-START-CR

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

TAGVEN

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer

NEOTRAPSCAL

Feasibility of the Maastro Applicator in Rectal Cancer

Impact Of Metformin In Rectal Cancer Patients

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

KEYMOVE

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

PTCy-PMAT

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Study on the Applicability of CCR Criteria in Rectal Cancer

ABLATIVE-2

SAVED LUNG

CCHOWW

Neoadjuvant 5-fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Weekly Paclitaxel and Trastuzumab in Her2 Positive Breast Cancer

Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer

WIDEA

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

WoW

SarQuantIRM

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

BREAKFAST-2

PIK3CA in HER2+ BC and pCR Trial

BIOPSY

PRISM

MR-AI-pCR

Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer

TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer

GRECCAR6

VAB

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

GIRO_ctDNA